Remote monitoring and virtual clinic for patients with respiratory conditions
An estimated 10,400 people in the UK have cystic fibrosis (CF) which affects the lungs, digestive system and several other organs. A pilot study of remote lung monitoring technology involved patients being treated for the disease at London’s Royal Brompton Hospital.
Patients with cystic fibrosis require frequent hospital visits to monitor their lung health. The average cystic fibrosis patient typically visits hospital five to six times a year, with each visit requiring 150 minutes of travelling and costing £39.
The aim is to make self-monitoring possible for all CF patients. Being able to test lung function at home would allow patients to monitor their lung health more frequently and effectively, decrease inconvenient hospital visits and help identify any deterioration in lung health sooner.
Solution and impact
The Royal Brompton Hospital worked with NuvoAir to support people with cystic fibrosis to monitor their lung health from home with a digital spirometer and self-monitoring app on their smartphone. This data can then be shared and viewed by the clinical team and virtual consultations completed to reduce the burden on in-hospital clinic appointments.
The technology also supports other respiratory conditions, such as asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung transplant. As a result, patients with CF have benefitted from a reduction in travel time, costs and time off work, as well as a 30% reduction in clinic appointments. Additionally, patients can monitor lung health twice as frequently, allowing an early identification of any deterioration.
The solution is a remote device to be used at home by the patient and linked to a smartphone to record the results.
Patients can complete a spirometry at home and results can be remotely monitored via smartphone and specialist CF clinical team at the Royal Brompton Hospital during virtual consultations.
The device is used at home by patients.
“Giving patients the ability to measure their own lung health has reduced the need to bring patients to hospital so often. It means they have a better idea how stable they are and if new treatments are working. We can then have conversations about their data over the phone or the internet instead of bringing them to clinic, making better use of our time and theirs.”
Dr Susan Madge, CF nurse consultant at Royal Brompton and Harefield NHS Foundation Trust.
Find out more
Download further information from the NuvoAir website (PDF, 392 KB)
Dr Susan Madge, CF nurse consultant at Royal Brompton Hospital
Helen Parrott, clinical lead, Nuvoair
These case studies summarise user and patient experiences with digital solutions along the relevant care pathway. Unless expressly stated otherwise, the apps and digital tools referenced are not supplied, distributed or endorsed by NHSX, NHS England and NHS Improvement or the Department of Health and Social Care and such parties are not liable for any injury, loss or damage arising from their use.
All playbook case studies have either passed, or are currently undergoing the Digital Technology Assessment Criteria (DTAC) assessment.
Please note the full legal disclaimer: NHSX playbook disclaimer